Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 45 EP applications James Alexander Warner has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11709244

SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS

IPC classification:
A61P 9/00, A61P 29/00, C07D 471/04, C07D 473/00, C07D 487/04, A61K 31/437, A61K 31/4985, A61K 31/52
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11730505

PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN

IPC classification:
A61P 25/02, A61P 25/04, A61K 31/513, A61K 31/53
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11731200

METHODS OF TREATMENT USING STERCULIC ACID

IPC classification:
A61P 25/28, A61P 29/00, A61K 31/201
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12761308

VANCOMYCIN DERIVATIVES

IPC classification:
A61K 38/14, A61K 47/00
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723013

L-PROLINE AND CITRIC ACID CO-CRYSTALS OF (2S, 3R, 4R, 5S, 6R )- 2- (3- ((5- (4-FLUOROPHENYL)THIOPHEN-2-YL) METHYL) -4-METHYLPHENYL)-6- (HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

IPC classification:
C07D 409/10, C07H 7/04, A61K 31/70
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12723011

HERBAL COMPOSITION FOR TREATING CANCER

IPC classification:
A61P 35/00, A61K 36/074, A61K 36/11, A61K 36/17, A61K 36/24, A61K 36/344, A61K 36/41, A61K 36/481, A61K 36/539, A61K 36/748
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12754568

SOLID DISPERSION FORMULATIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 9/16, A61K 9/48, A61K 31/495
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12724044

PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITTORS OF SGLT-2

IPC classification:
C07D 407/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12724507

PICOLINAMIDO - PROPANOIC ACID DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS

IPC classification:
A61P 31/10, C07D 213/81, A61K 31/4412
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14152531

Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino] heptanoic acid S,S dioxide and methods of making and using the same

IPC classification:
C07D 229/00, C07D 267/12, C07D 281/02
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12738273

CRYSTAL STRUCTURE OF THE PRO FORM OF A MATRIX METALLOPROTEINASE AND AN ALLOSTERIC PROCESSING INHIBITOR

IPC classification:
C12N 9/64, G06F 19/16
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12737644

METHODS OF TREATMENT USING ALLOSTERIC PROCESSING INHIBITORS FOR MATRIX METALLOPROTEINASES

IPC classification:
A61K 31/428
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12844612

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

IPC classification:
A61P 1/16, A61K 31/38, A61K 31/385, A61K 31/554
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12781920

STABLE POVIDONE-IODINE COMPOSITIONS WITH STEROIDS OR NON-STEROIDAL ANTI-INFLAMMATORIES

IPC classification:
A61P 27/02, A61K 9/06, A61K 9/10, A61K 31/56, A61K 31/573, A61K 31/79
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12801442

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

IPC classification:
A61P 1/16, A61K 31/155, A61K 31/38, A61K 31/41, A61K 31/4436, A61K 31/495, A61K 31/4965, A61K 31/4985, A61K 31/4995, A61K 31/5377, A61K 31/554, A61K 31/7042, A61K 45/06
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11813088

METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE

IPC classification:
A61P 21/00, A01N 37/18, A61K 31/16
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP13711186

SPRAY DRIED FORMULATIONS

IPC classification:
A61P 31/18, A61K 9/00, A61K 9/14, A61K 9/20, A61K 31/5377, A61K 47/32, A61K 47/38
Applicant:
Gilead Sciences Inc
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11730504

PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN

IPC classification:
A61P 25/02, A61P 25/04, A61K 31/513, A61K 31/53
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11719136

MODULATORS OF FATTY ACID AMIDE HYDROLASE

IPC classification:
A61P 3/00, A61P 3/10, A61P 9/12, A61P 15/00, A61P 19/10, A61P 25/16, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, A61P 29/00, A61P 35/00, A61P 37/06, C07D 405/12, A61K 31/496
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11831241

ALPHA-KETOAMIDE DERIVATIVES USEFUL ENDOTHELIAL LIPASE INHIBITORS

IPC classification:
A61P 9/10, C07D 271/10, C07D 285/12, C07D 417/12, A61K 31/41
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11771300

OXOPIPERAZINE-AZETIDINE AMIDES AND OXODIAZEPINE-AZETIDINE AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

IPC classification:
A61P 29/00, C07D 403/04, C07D 403/14, C07D 409/14, C07D 417/14, A61K 31/506
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790442

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/54
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13865757

LFA-1 INHIBITOR FORMULATIONS

IPC classification:
A61K 31/343
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13861342

OLIGONUCLEOTIDE FORMULATION

IPC classification:
C07H 21/00
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14701647

THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61P 31/18, C07D 487/04, C07D 513/04
Applicant:
Gilead Sciences Inc
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11735350

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A01N 43/00
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12702948

USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY

IPC classification:
A61P 25/14, A61K 31/44
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11784828

PIPERIDIN-4-YL-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

IPC classification:
A61P 29/00, C07D 205/04, C07D 211/16, C07D 401/04, C07D 401/14, C07D 409/14, C07D 413/14, C07D 417/12, C07D 417/14, A61K 31/4523
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196573

2-aminopyrimidine modulators of the histamine h4 receptor

IPC classification:
A61P 29/00, C07D 239/48, C07D 403/04, C07D 405/14, C07D 409/14, C07D 471/04, C07D 487/08, C07D 487/10, C07D 519/00, A01N 43/40, A61K 31/445, A61K 31/506
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11778748

AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS

IPC classification:
A61P 25/00, A61P 29/00, C07D 403/12, C07D 405/14, C07D 409/14, C07D 417/14, A61K 31/381, A61K 31/4025, A61K 31/427
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11708663

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-1 (DPP-1)

IPC classification:
A61P 19/02, C07D 211/66, C07D 401/06, C07D 407/06, C07D 407/14, C07D 409/06, C07D 409/14, C07D 417/06, C07D 417/14, A61K 31/4375, A61K 31/4436, A61K 31/4439, A61K 31/444
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11837527

IMIDAZOLE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF

IPC classification:
A61P 1/00, A61P 15/14, A61P 19/02, A61P 25/00, A61P 25/08, A61P 25/18, A61P 25/24, A61P 25/28, A61P 29/00, A61P 35/00, C07D 401/14, A61K 31/4439
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15199440

DIRECT COMPRESSION FORMULATION AND PROCESS

IPC classification:
A61K 9/20
Applicant:
Novartis AG
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11718824

INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS

IPC classification:
A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/12, C07D 231/56, C07D 401/04, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/10, C07D 403/12, C07D 471/04, C07D 487/04, C07D 487/10, A61K 31/416, A61K 31/4745, A61K 31/519
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11726605

CYCLOHEXYL-AZETIDINYL ANTAGONISTS OF CCR2

IPC classification:
A61P 1/02, A61P 3/10, A61P 11/06, C07D 401/14, C07D 403/12, C07D 403/14, C07D 413/14, C07D 417/14, C07D 471/04, A61K 31/416, A61K 31/423, A61K 31/437
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11721616

PHARMACEUTICAL FORMULATIONS COMPRISING 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT

IPC classification:
A61P 3/10, A61K 9/20, A61K 9/28, A61K 31/381, A61K 31/7004, A61K 31/7042, A61K 47/26, A61K 47/38
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11817037

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A01N 43/50, A61K 31/415
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11749643

4-AMINOQUINAZOLIN-2-YL-1-PYRRAZOLE-4-CARBOXYLIC ACID COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS

IPC classification:
A61P 3/10, A61P 9/00, C07D 403/04, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, A61K 31/517, A61K 31/55
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729234

CYCLOHEXYL-AZETIDINYL ANTAGONISTS OF CCR2

IPC classification:
A61P 29/00, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, C07D 471/04, A61K 31/4375, A61K 31/4709, A61K 31/502, A61K 31/517
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755498

DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS

IPC classification:
A61P 29/00, C07D 205/04, C07D 403/14, C07D 409/14, C07D 413/14, C07D 417/12, C07D 417/14, C07D 513/04, A61K 31/427, A61K 31/429
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799927

PROCESS FOR THE PREPARATION OF METHYLPHENIDATE AND PHARMACEUTICAL SALTS THEREOF

IPC classification:
C07D 211/34
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11746081

ABSORBABLE PEG-BASED HYDROGELS

IPC classification:
C08G 65/329, C08G 65/334, A61K 9/51
Applicant:
Janssen Biotech, Inc.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11726017

SUBSTITUTED 2'-AMINO AND 2'-THIO-BICYCLIC NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM

IPC classification:
C07H 19/073, C07H 19/173, C07H 21/04, C12N 15/113
Applicant:
Isis Pharmaceuticals, Inc.
Applicant:
Ionis Pharmaceuticals, Inc.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11706982

AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS

IPC classification:
A61P 19/00, C07D 417/06, C07D 417/14, A61K 31/427, A61K 31/4439
Applicant:
Janssen Pharmaceutica N.V.
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15771373

TRICYCLIC HETEROCYCLES FOR USE AS BET PROTEIN INHIBITORS

IPC classification:
A61P 29/00, A61P 31/12, A61P 35/00, C07D 498/06, A61K 31/5365
Applicant:
Incyte Holdings Corporation
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature